-15%

Unizink 50 enteric coated tablets

Original price was: රු3,529.Current price is: රු3,000.

Combat zinc deficiency effectively with Unizink 50, the enteric-coated tablets designed for optimal absorption. Each tablet delivers a precise dose of Zinc Aspartate, essential for those unable to meet their zinc needs through diet alone. Suitable for children over one year and adults, including during pregnancy and lactation. Always consult your healthcare provider before use, especially if you have pre-existing conditions or are taking other medications. Store below 25°C and do not freeze.

Availability: Out of stock SKU: 0689 Categories: , Tags: , ,
Compare

Description

For the treatment of zinc deficiency States, the nutrition can be not fixed.

Important Information (Mandatory Information):

Unizink® 50 . Active Ingredient: Zinc Aspartate. Areas of application: For the treatment of zinc deficiency in the diet is not conditions, moderately be fixed can..

To be the risks and side effects read the leaflet and ask your doctor or pharmacist.

Use of information

Unizink® 50
50 mg, enteric coated tablets, for children from 1 year and Adult
Active Ingredient: Zinc Aspartate

Material and indication group or mode of action
Mineral Preparation, Zinc-Substitution (Feed)

Areas of application

For the treatment of zinc deficiency in the diet is not conditions, moderately can be fixed.

Contraindications

  • Hypersensitivity to the active substance or to any of the other The components of the drug. Severe Renal Parenchymal Disease, acute renal failure.
    This medicinal product contains Sorbitol. Please contact Unizink® 50 only after consultation with your doctor, if you know that you have an intolerance to some sugars suffering.
    Application in pregnancy and lactation
    In the case of a proven, clinically-resistant zinc deficiency in the exists the therapeutic dose range, no
    Restriction to the intake of Unizink® 50 in pregnancy and lactation.

Side effects

  • After prolonged application of Unizink® 50 can be a copper deficiency cause.
    Please inform your doctor or pharmacist if you side effects notice that are not listed in this leaflet.

Interactions with other drugs

  • Zinc reduces the absorption of Tetra cyklinen. Between the Taking these medicines should have a temporal distance of a minimum of 4 hours will be adhered to. Chelating agents such as D-penicillamine, DMPS, or EDTA the absorption of zinc reduce or excretion increase. The absorption of Ofloxacin and other Class is affected by zinc. The simultaneous administration of iron-, copper -, or calcium salts reduces the absorption of zinc. Foods with a high Phytinanteil (e.g., grain products, legumes, nuts) reduce the absorption of zinc.

Warnings

  • In the case of long-term intake of zinc in both the copper- as well as the zinc level to be monitored.

Dosage instructions

  • Unless otherwise prescribed, take children between 1 and 10 Years daily 1 tablet, growing according to the Body weight) daily 1 to 2 tablets, adults and Pregnant women and lactating mothers a day 2 tablets.

Type of application

  • The tablets are to be swallowed whole and ungelutscht with liquid to swallow, preferably approximately 30-60 minutes before meals.

Duration of the application

  • Unizink® 50 is the recommended dose for long-term use several months suitable.

Type of storage

  • Do not store above 25°C. do not freeze.

Composition

  • 1 gastro-resistant tablet contains:

Active substance:

  • 50 mg of zinc-bis-(hydrogen DL-aspartate) = 10 mg of zinc.

Other Ingredients:

  • Microcrystalline Cellulose, Sorbitol, Triethyl Citrate, Croscarmellose – sodium, talc, titanium dioxide, Boeson VP, Magnesium stearate, Macrogol 6000, Eudragit L 30 E/L to 12.5.

Dosage form and content of:

  • Gastro-resistant tablet, in packs of 20 (N1), 50 (N2) and 100 (N3) gastric juice-resistant tablets. Prison, packs of 500 (10×50) and 1000 (10×100) enteric tablets.

Reviews

There are no reviews yet.


Be the first to review “Unizink 50 enteric coated tablets”

General Inquiries

There are no inquiries yet.